Conservation of Resistance-Nodulation-Cell Division Efflux Pump-Mediated Antibiotic Resistance in Burkholderia cepacia Complex and Burkholderia pseudomallei Complex Species.

Anti-Bacterial Agents / pharmacology Burkholderia cepacia complex / genetics Burkholderia pseudomallei / genetics Cell Division Drug Resistance, Microbial Drug Resistance, Multiple, Bacterial Microbial Sensitivity Tests
Burkholderia RND efflux pumps multidrug resistance

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
17 08 2021
Historique:
pubmed: 29 6 2021
medline: 25 8 2021
entrez: 28 6 2021
Statut: ppublish

Résumé

Burkholderia cepacia complex (Bcc) and Burkholderia pseudomallei complex (Bpc) species include pathogens that are typically multidrug resistant. Dominant intrinsic and acquired multidrug resistance mechanisms are efflux mediated by pumps of the resistance-nodulation-cell division (RND) family. From comparative bioinformatic and, in many instances, functional studies, we infer that RND pump-based resistance mechanisms are conserved in

Identifiants

DOI: 10.1128/AAC.00920-21 PMID: 34181473 PMC: PMC8370192
pubmed: 34181473
doi: 10.1128/AAC.00920-21
pmc: PMC8370192
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0092021

Références

BMC Microbiol. 2009 Sep 17;9:200
pubmed: 19761586
PLoS One. 2013 Dec 27;8(12):e84068
pubmed: 24386333
Bioinformatics. 2008 Dec 1;24(23):2803-4
pubmed: 18842600
BMC Genomics. 2019 Nov 4;20(1):803
pubmed: 31684866
Future Microbiol. 2012 Dec;7(12):1389-99
pubmed: 23231488
Antimicrob Agents Chemother. 2013 Sep;57(9):4381-6
pubmed: 23817379
Front Microbiol. 2015 Apr 14;6:305
pubmed: 25926825
Mol Microbiol. 2012 Jan;83(2):362-78
pubmed: 22171913
Antimicrob Agents Chemother. 1999 Mar;43(3):465-70
pubmed: 10049252
mBio. 2016 Sep 20;7(5):
pubmed: 27651357
Antimicrob Agents Chemother. 2021 Feb 17;65(3):
pubmed: 33318011
BMC Genomics. 2011 Jul 22;12:373
pubmed: 21781329
Microb Genom. 2021 Jan;7(1):
pubmed: 33459584
Microb Ecol. 2012 Feb;63(2):249-66
pubmed: 21850446
Genes (Basel). 2018 Aug 01;9(8):
pubmed: 30071618
Curr Opin Pulm Med. 2005 Nov;11(6):528-33
pubmed: 16217180
J Clin Invest. 2004 Feb;113(3):464-73
pubmed: 14755343
Drug Resist Updat. 2016 Sep;28:82-90
pubmed: 27620956
Antimicrob Agents Chemother. 2010 Aug;54(8):3113-20
pubmed: 20498323
Antimicrob Agents Chemother. 2017 May 24;61(6):
pubmed: 28396541
Antimicrob Agents Chemother. 2014;58(1):162-6
pubmed: 24145517
Appl Environ Microbiol. 2010 May;76(10):3170-6
pubmed: 20348312
Genome Announc. 2013 Oct 17;1(5):
pubmed: 24136849
PLoS Negl Trop Dis. 2009 Sep 22;3(9):e519
pubmed: 19771149
J Antimicrob Chemother. 2011 Jan;66(1):73-8
pubmed: 20965890
Front Microbiol. 2017 Aug 22;8:1592
pubmed: 28878751
Nat Rev Microbiol. 2005 Feb;3(2):144-56
pubmed: 15643431
PLoS One. 2014 Aug 25;9(8):e104986
pubmed: 25153194
PLoS One. 2011 Feb 09;6(2):e16892
pubmed: 21347382
FEMS Microbiol Lett. 2007 Dec;277(2):115-22
pubmed: 18031330
PLoS One. 2011;6(12):e28831
pubmed: 22216120
Nucleic Acids Res. 2019 Jul 2;47(W1):W636-W641
pubmed: 30976793
PLoS One. 2011 Apr 19;6(4):e18902
pubmed: 21526150
Nucleic Acids Res. 1990 Sep 11;18(17):5019-26
pubmed: 2402433
Appl Environ Microbiol. 2010 Feb;76(4):1095-102
pubmed: 20023084
mBio. 2017 Sep 5;8(5):
pubmed: 28874476
Microbiology (Reading). 2018 Sep;164(9):1156-1167
pubmed: 30024368
Nat Methods. 2015 Jan;12(1):59-60
pubmed: 25402007
Antimicrob Agents Chemother. 2017 May 24;61(6):
pubmed: 28348161
Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0061121
pubmed: 34097494
Antimicrob Agents Chemother. 2014 Dec;58(12):7424-9
pubmed: 25267676
Antimicrob Agents Chemother. 2004 Apr;48(4):1128-35
pubmed: 15047512
J Cyst Fibros. 2011 Jul;10(4):291-2
pubmed: 21288782
Ann Clin Microbiol Antimicrob. 2014 Jan 06;13:2
pubmed: 24393536
mBio. 2020 Apr 14;11(2):
pubmed: 32291300
FEMS Microbiol Lett. 2005 Apr 15;245(2):337-44
pubmed: 15837391
Nat Rev Dis Primers. 2018 Feb 01;4:17107
pubmed: 29388572

Auteurs

Nawarat Somprasong (N)

The Pathogen and Microbiome Institute, Northern Arizona Universitygrid.261120.6, Flagstaff, Arizona, USA.

Jinhee Yi (J)

The Pathogen and Microbiome Institute, Northern Arizona Universitygrid.261120.6, Flagstaff, Arizona, USA.

Carina M Hall (CM)

The Pathogen and Microbiome Institute, Northern Arizona Universitygrid.261120.6, Flagstaff, Arizona, USA.

Jessica R Webb (JR)

Global and Tropical Health Division, Menzies School of Health Researchgrid.271089.5, Charles Darwin University, Darwin, Northern Territory, Australia.

Jason W Sahl (JW)

The Pathogen and Microbiome Institute, Northern Arizona Universitygrid.261120.6, Flagstaff, Arizona, USA.

David M Wagner (DM)

The Pathogen and Microbiome Institute, Northern Arizona Universitygrid.261120.6, Flagstaff, Arizona, USA.

Paul Keim (P)

The Pathogen and Microbiome Institute, Northern Arizona Universitygrid.261120.6, Flagstaff, Arizona, USA.

Bart J Currie (BJ)

Global and Tropical Health Division, Menzies School of Health Researchgrid.271089.5, Charles Darwin University, Darwin, Northern Territory, Australia.
Department of Infectious Diseases and Northern Territory Medical Program, Royal Darwin Hospital, Darwin, Northern Territory, Australia.

Herbert P Schweizer (HP)

The Pathogen and Microbiome Institute, Northern Arizona Universitygrid.261120.6, Flagstaff, Arizona, USA.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male

Management of the infected total elbow arthroplasty.

Joaquin Sanchez-Sotelo
1.00
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents

Mathematical modeling of vancomycin release from Poly-L-Lactic Acid-Coated implants.

Papon Thamvasupong, Kwanchanok Viravaidya-Pasuwat
1.00
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Menthol as an effective inhibitor of quorum sensing and biofilm formation in Candida albicans and Candida glabrata by targeting the transcriptional repressor TUP1.

Pouria Khodavandi, Maryam Miri Soogh, Fahimeh Alizadeh et al.
1.00
Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Conservation of Resistance-Nodulation-Cell...
questionsmedicales.fr › Bactéries › Proteobacteria › Betaproteobacteria › Burkholderiales › Burkholderiaceae › Burkholderia › Burkholderia cepacia complex › Conservation of Resistance-Nodulation-Cell...
questionsmedicales.fr › Bactéries › Proteobacteria › Betaproteobacteria › Burkholderiales › Burkholderiaceae › Burkholderia › Burkholderia pseudomallei › Conservation of Resistance-Nodulation-Cell...
questionsmedicales.fr › Phénomènes physiologiques › Croissance et développement › Croissance › Processus de croissance cellulaire › Prolifération cellulaire › Division cellulaire › Conservation of Resistance-Nodulation-Cell...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Conservation of Resistance-Nodulation-Cell...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Multirésistance aux médicaments › Multirésistance bactérienne aux médicaments › Conservation of Resistance-Nodulation-Cell...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Conservation of Resistance-Nodulation-Cell...